Hologic, Inc. (NASDAQ:HOLX) recently reported plans to release its fourth quarter fiscal 2010 operating results on Monday, November 8, 2010 after market close. In conjunction with the release, management will host a conference call on Monday, November 8, 2010, at 5:00 p.m. (eastern).

Hologic, Inc. develops, manufactures, and distributes medical imaging systems, and diagnostic and surgical products for serving the healthcare needs of women.

****

Centennial Bank, a wholly-owned subsidiary of Home BancShares, Inc. (NASDAQ:HOMB), reported it has acquired all the deposits, substantially all of the assets, and certain liabilities of Wakulla Bank (”Wakulla”) headquartered in Crawfordville, Florida (located in the Tallahassee MSA), through loss-sharing agreements with the Federal Deposit Insurance Corporation (”FDIC”).

Home BancShares, Inc. operates as a holding company for the Centennial Bank that provides various commercial and retail banking, and related financial products and services to businesses, real estate developers, investors, individuals, and municipalities.

****

Power3 Medical Products, Inc. (PWRM.OB) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

PWRM recently reported that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro, Power3’s diagnostic test, and focused on Power3’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

“We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” said Helen R. Park, MS, Chief Executive Officer of Power3, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”

“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

In addition, PWRM has filed several patent applications for its NuroPro technology that are currently pending.

For more information about this company please visit http://www.power3medical.com

****

Hollysys Automation Technologies, Ltd. (NASDAQ:HOLI) recently reported that it has won the bidding to supply its ground-based high-speed rail signaling system for the Qinhuangdao-Shenyang high-speed railway line.

The contract value totaled approximately US $11.8 million, or RMB 79.5 million. Qinhuangdao-Shenyang Line connects Qinhuangdao in Hebei province and Shenyang in Liaoning province, with 404 km in total length.

Hollysys Automation Technologies Limited provides automation and control technology and applications in the People?s Republic of China.

CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.

Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup

PLEASE BE SURE TO VISIT CRWESELECT.NING.COM

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB).

PWRMcrweselect1013